AMERICAN INTERNATIONAL GROUP, INC. - ARCUS BIOSCIENCES INC ownership

ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 79 filers reported holding ARCUS BIOSCIENCES INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
AMERICAN INTERNATIONAL GROUP, INC. ownership history of ARCUS BIOSCIENCES INC
ValueSharesWeighting
Q1 2024$547,784
-2.0%
29,014
-0.9%
0.00%0.0%
Q4 2023$558,981
+7.4%
29,266
+1.0%
0.00%
-33.3%
Q3 2023$520,281
-9.5%
28,985
+2.4%
0.00%
-25.0%
Q2 2023$575,139
+12.3%
28,318
+0.8%
0.00%
+33.3%
Q1 2023$512,307
-11.4%
28,087
+0.4%
0.00%
-25.0%
Q4 2022$578,358
-21.5%
27,967
-0.7%
0.00%
-20.0%
Q3 2022$737,000
+5.9%
28,176
+2.5%
0.01%0.0%
Q2 2022$696,000
-0.9%
27,477
+23.4%
0.01%
+25.0%
Q1 2022$702,000
-27.2%
22,258
-6.6%
0.00%
-20.0%
Q4 2021$964,000
+11.4%
23,823
-3.9%
0.01%0.0%
Q3 2021$865,000
+24.1%
24,797
-2.3%
0.01%
+150.0%
Q2 2021$697,000
+1.0%
25,386
+3.3%
0.00%0.0%
Q1 2021$690,000
+8.5%
24,567
+0.3%
0.00%0.0%
Q4 2020$636,000
+47.2%
24,502
-2.8%
0.00%0.0%
Q3 2020$432,000
-13.3%
25,205
+25.2%
0.00%0.0%
Q2 2020$498,000
+86.5%
20,138
+4.8%
0.00%
+100.0%
Q1 2020$267,000
+30.2%
19,219
-5.5%
0.00%0.0%
Q4 2019$205,000
+9.6%
20,328
-0.8%
0.00%0.0%
Q3 2019$187,000
+17.6%
20,500
+2.2%
0.00%0.0%
Q2 2019$159,000
-36.4%
20,050
+0.2%
0.00%0.0%
Q1 2019$250,000
+12.1%
20,013
-3.1%
0.00%0.0%
Q4 2018$223,000
+159.3%
20,663
+235.4%
0.00%
Q3 2018$86,000
+109.8%
6,160
+83.0%
0.00%
Q2 2018$41,0003,3660.00%
Other shareholders
ARCUS BIOSCIENCES INC shareholders Q2 2019
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 1,612,077$29,404,28419.15%
Decheng Capital Management III (Cayman), LLC 869,790$15,864,9706.40%
Octagon Capital Advisors LP 2,172,000$39,617,2805.70%
Boxer Capital, LLC 1,432,200$26,1231.28%
PFM Health Sciences, LP 1,559,947$28,453,4331.26%
SECTORAL ASSET MANAGEMENT INC 293,646$5,356,1031.03%
DAFNA Capital Management LLC 175,217$3,195,9580.96%
Ikarian Capital, LLC 230,000$4,195,2000.95%
Tejara Capital Ltd 50,000$912,0000.47%
Capital Impact Advisors, LLC 20,501$373,9380.46%
View complete list of ARCUS BIOSCIENCES INC shareholders